De Sanctis, V. (2022) “The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network: Oral glucose-lowering agents (GLAs) in β-thalassemia patients”, Acta Biomedica Atenei Parmensis, 93(2), p. e2022162. doi:10.23750/abm.v93i2.12056.